The U.S. Center for the Evaluation of Risks to Human Reproduction "was established within the National Institutes of Health to assess the dangers of chemicals and help determine which ones should be regulated," reports Marla Cone. "But much of the agency's work has been conducted by a private consulting company ...

"The biggest leveraged buyout in history was notable not only for its finances, but also for its unusual feature of having multiple PR firms advising both sides of the deal simultaneously," writes PR Week.